v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (970,972) $ (328,547)
Adjustments to reconcile net loss to net cash used in operating activities    
Amortization expense 14,451 12,422
Stock-based compensation expense 280,830 76,597
Common stock issued in exchange for services 250,000
Non-cash operating lease effect (620)
Net gain from change in fair value of derivative liability instruments (697,561)
Amortization of deferred offering cost 477,647
Changes in operating assets and liabilities:    
Prepaids and other current assets (123,738) (287,141)
Accounts payable and accrued expenses (613,464) (20,769)
Net cash used in operating activities (1,632,807) (298,058)
Cash flows from investing activities:    
Purchases of intangible assets (12,227)
Net cash used in investing activities (12,227)
Cash flows from financing activities:    
Proceeds from issuance of common stock, net of issuance costs 998,092
Cash receipt from stock subscription receivable 1,070,000
Proceeds from Avenue Capital Loan Agreement 6,716,561
Net cash provided by financing activities 7,786,561 998,092
Net increase (decrease) in cash and cash equivalents 6,141,527 700,034
Cash and cash equivalents at beginning of the period 5,076,144 872,599
Cash and cash equivalents at end of the period 11,217,671 1,572,633
Supplemental disclosure of non-cash activities    
Issuance of common stock under Avenue Capital Agreement $ 1,050,967